Loading organizations...
Amkey Ventures operates as a specialized venture capital firm, providing equity capital to early-stage companies in the biomedical technology sector. The firm identifies and supports promising ventures developing cutting-edge healthcare and life science solutions. It applies rigorous due diligence, leveraging deep scientific understanding to pinpoint high-growth opportunities.
Established in 2001, the firm was co-founded by individuals including general partner George J. Lee. Dr. Lee's background, with a Ph.D. in Chemistry and extensive entrepreneurial experience in healthcare, informed the core insight. He recognized the critical need for specialized capital and guidance for nascent biomedical companies transforming medical treatment.
Amkey Ventures' portfolio includes companies pioneering advancements in diverse biomedical fields, acting as a vital financial partner. The firm empowers innovative entities to transition from development to market readiness. Its vision centers on accelerating transformative biomedical innovations, improving patient outcomes and reshaping global health via strategic early-stage investments.
Amkey Ventures has 1 tracked investment across 1 company. The latest tracked deal is $24.3M Series B in Armetheon in February 2015.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 5, 2015 | Armetheon | $24.3M Series B | Capital TEN, Hercules Bioventures Partners | Larry HSU, Stefan Roever, CDIB Capital Group, ID Softcapital Group |